AUG 14, 2019 01:52 PM PDT

Promising Drug Encourages Survival in Pancreatic Cancer

WRITTEN BY: Nouran Amin

Building on almost 20 years of research, a phase 1 clinical trial drug for pancreatic cancer, named ‘AZD1775’, shows promising initial results in a new report by the University of Michigan Rogel Cancer Center. The study was focused on developing therapeutic treatments for pancreatic cancer patients that are on stages far too advanced for surgical interventions. The drug, AZD1775, was designed to work on inhibiting the effects of an enzyme known as ‘Wee1’ for it role in DNA damage repair in cancer cells.

Learn more on Pancreatic Cancer:

"If we can disable the DNA damage response in pancreatic cancer cells, it might eliminate treatment resistance and sensitize the cancer to the effects of both radiation and chemotherapy," says lead study author Kyle Cuneo, M.D., associate professor of radiation oncology at Michigan Medicine.

Current standard treatments drugs involve gemcitabine along with radiotherapy that damage the DNA of cancer cells. However, these treatments are overcome by the cancer as it has its one way of repairing the damage caused by treatments. The limit of effectiveness of these standard treatments has prompted researchers to develop AZD1775—which is unique in leaving normal cells unaffected while shielding the protection away from pancreatic cancer against the effects of radiotherapy and gemcitabine.

"If we're ever going to cure pancreatic cancer, we're going to need effective systemic treatment as well as local therapy. Our data suggests that AZD1775 can do both," says senior study author Ted Lawrence, M.D., Ph.D., Isadore Lampe Professor and chair of radiation oncology at Michigan Medicine.

"Adding AZD1775 to radiation and gemcitabine was relatively well tolerated with encouraging survival results. Further studies with this promising combination are needed," Cuneo says.

Source: Science Daily

About the Author
  • Nouran enjoys writing on various topics including science & medicine, global health, and conservation biology. She hopes through her writing she can make science more engaging and communicable to the general public.
You May Also Like
OCT 21, 2019
Microbiology
OCT 21, 2019
Picturing a New Kind of Antibiotic
Scientists have deciphered the X-ray crystal structure of an enzyme that generates a unique broad spectrum antibiotic called obafluorin....
OCT 21, 2019
Technology
OCT 21, 2019
Computer Model Advances New Therapeutics for Sickle Cell Anemia
A team of Brown University researchers has developed a new computer model that simulates the way red blood cells become misshapen by sickle cell anemia. A ...
OCT 21, 2019
Drug Discovery & Development
OCT 21, 2019
A Diabetic Drug that Promotes Brain Repair...But it Only Works in Females
Gender discrimination in research has long stopped serious advancements. In neuroscience, scientists believed that male brains are straightforward and do n...
OCT 21, 2019
Genetics & Genomics
OCT 21, 2019
Gene-Editing Breakthrough for Cervical Cancer
Researchers at the The Menzies Health Institute Queensland have found a way to use gene therapy CRISPR-Cas9 to treat cervical cancer. The first treatment o...
OCT 21, 2019
Cannabis Sciences
OCT 21, 2019
CBD Extract for Cannabis Addiction
Some people believe the secret to curing a hangover is to drink more alcohol the morning after a night of binge drinking - “the hair of the dog that...
OCT 21, 2019
Drug Discovery & Development
OCT 21, 2019
Therapeutic To Treat The Detrimental Effects of Marijuana
As U.S. states continue to legalize the use of marijuana, so is the number of American women using cannabis before becoming pregnant and to treat morning s...
Loading Comments...